OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator. This document is also available as Markdown.

← Bedfordshire And Northamptonshire Multiple Sclerosis Therapy Centre Limited

2024-12-31-accounts

Charity registration number 802510

Company registration number 2296103 (England and Wales)

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

LEGAL AND ADMINISTRATIVE INFORMATION

Trustees Kay Taylor (Chair) Laurence Culhane (Vice chair) (Resigned in June 2024) Kevin Traynor (Treasurer) Melanie Hawman (Secretary) Susan Napper Jean-Pierre Brown Alex Scott (Resigned in July 2024) Elizabeth Toogood Maggie Marshall Huseyin Huseyin Luke Hopkins (Appointed in June 2024) Karen Lathaen (Appointed in January 2025) Secretary Melanie Hawman Charity number 802510 Company number 2296103 Principal address Bradbury House 155 Barkers Lane Bedford England MK41 9RX Independent examiner Caroline Brazier ACA DChA Cansdales Business Advisers Limited Chartered Accountants St Mary’s Court The Broadway Old Amersham Bucks HP7 0UT Bankers HSBC 12 Allhallows Bedford MK40 1LJ

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

CONTENTS

Page
Trustees' report 1 - 11
Independent examiner's report 12
Statement of financial activities 13
Balance sheet 14
Notes to the financial statements 16 - 27

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) FOR THE YEAR ENDED 31 DECEMBER 2024

The trustees present their annual report and financial statements for the year ended 31 December 2024.

The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the financial statements and comply with the charitable company's governing document, the Companies Act 2006, FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)".

Structure, governance and management

The charitable company is managed by the Executive Committee, which meets on a six to eight weekly basis. They are responsible for setting policies and procedures, deciding on budgets, salaries, therapies and services to be provided. The Executive Committee members, who are also Trustees of the company, are elected at the Annual General Meeting (AGM).

Objectives and activities

The principal activity and charitable object is to provide facilities to improve the condition of people living with Multiple Sclerosis (MS). There has been no material change in the policies adopted since the last report.

Bedfordshire and Northamptonshire Multiple Sclerosis Therapy Centre Limited co-operates with other MS charities in the pursuit of its charitable objective.

Established in 1983, and successfully providing services for 42 years, our vision is Providing professional specialist therapies and support for people living with MS, their carers, friends and families, throughout their illness, in a friendly, self-help environment.

The charitable company offers a range of therapies in order to further its objectives. The therapies provided are wide-ranging, and include:

Our beneficiaries can access these services for as long as needed, with minimal waiting times, all in one convenient location. The therapies provided, offer significant benefits and would otherwise be costly or inaccessible.

The impact of our services make to people living with MS is great:

The benefits to society are wide-ranging, including reduced costs to the NHS and local authorities in medical and social care services. This is because individuals can maintain their independence for longer and are less likely to require hospital services as compared to those who do not have access to the MS Therapy Centre.

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

Furthermore, by maintaining mobility, individuals are able to remain in the workforce longer, thus contributing to the economy by paying taxes.

Additionally, the cost of benefits is reduced, with lower initial claims for PIP and a delay in the transition to dependence on ESA/UC in the long term.

The trustees have fulfilled their duty to consider the public benefit guidance when exercising their powers and responsibilities, ensuring that the relevant considerations were taken into account.

Our therapies and treatments are provided to anyone with MS, mostly living in Bedfordshire and Northamptonshire, and also to people living within a reasonable distance. MS Therapy Centres are present in other counties to serve those living elsewhere; we signpost people to these Centres and to statutory services as appropriate.

Our therapies are provided free of charge to any individual accessing the MS Therapy Centre. Service users make voluntary donations towards running costs, and they help with events and fundraising activities. We raise further funds from charitable trusts, companies, local groups and other individuals.

The therapies and treatments are provided for individuals with MS to help themselves - we are a self-help charity. This means that any individual with MS can decide for themselves which therapies they would like to access, if thought appropriate by the relevant therapist. Any therapy is undertaken with advice from the professional offering that therapy. The Trustees do not envisage any detriment or harm to anyone undertaking therapies as long as they are taken in accordance with the guidelines laid out by the MS Therapy Centre.

Achievement and Performance

Overview

2024 was marked by a number of developments in our services, all aligned to our strategic aims (see below). Notably, following the success of our trial for people living with Parkinson’s, we are now open to this cohort as well as people living with MS, supported by a grant from a local Trust.

Five year funding from the National Lottery, that commenced in January 2024, has further enhanced our confidence, positioning us for continued growth and new opportunities, ensuring long-term success and impact.

Our charity has exceeded expectations, surpassing most of our key targets for the year in engagement and health outcomes. We have delivered measurable improvements in both the physical and mental wellbeing of people within the MS and Parkinson’s communities. Additionally, we have increased contributions to community life through volunteering, while supporting the wellbeing of carers and families.

A notable achievement this year has been the significant rise in the number of therapies provided, driven by increased demand from users. We have expanded our service offerings, introducing additional group sessions and new classes tailored to various levels of disability. The number of therapy sessions delivered has increased from 8,800 sessions in 2023 to 11,628 in 2024.

Our commitment to outcomes has been strengthened with the implementation of the MSIS-29 survey (specific to MS) and a Parkinson’s-specific survey, both of which have produced positive feedback and confirm the impact we are making on users’ health and wellbeing.

A key indicator of our success is an increase in user donations from £84,733 in 2023 to £103,304 in 2024 - a 22% uplift, boosting our income and reinforcing the financial sustainability of our charity. Additionally, we have secured further funding, ensuring that our Parkinson’s project is now fully self-funded, which strengthens the overall resilience of the Centre.

FIVE STRATEGIC IMPERATIVES

1. Better Outcomes for our Service Users

Objectives:

To empower people to manage their symptoms holistically, providing an increased range of therapies and other support services, thus enabling informed choice and sustained changes where desired by the individual. This will include developing a suitable service for those people who are still working.

To provide information and advice to our service users such that they become experts by experience in their conditions and can self-manage their illness.

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

Achievements:

We have increased health benefits by providing more therapies including:

Providing information :

The following sessions were delivered in 2024:

We maintained contact with our service users through monthly online newsletters and social media activity. Regular service users are contacted by email to keep them informed of any new developments, and by email for appointment reminders.

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

. Further developments in 2025 will include:

Figure 1. Therapy sessions delivered in 2024

The total number of therapy sessions delivered in 2024 increased by 2,828 (32%).

Therapy usage : Some service users access several therapies each week. Some therapy slots are taken up by different service users in a 2 or 3 weekly cycle in order to maximise the number of people who are able to access each therapy).

2. Better Outcomes for more people

Objectives:

Achievements:

We engaged with 72 new service users over the year (44 with MS, 25 with Parkinson’s and 3 with other conditions). The number of new attendees with MS was fewer than last year (54 in 2023), but the increase in members with Parkinson’s has kept the charity growing (figs.2 and 3).

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2024

Typically, we maintain contact with over 700 people, up to 304 of whom attended the Centre over the year. Around 203 people attend regularly.

Our Service users are habitants of Bedfordshire, Northamptonshire and the surrounding counties.

We have progressed the number of people with Parkinson’s who use our services from a trial of 15 people to over 40 people. Parkinson’s users have access to all therapies, exercise sessions, and treatments at the Centre, including an additional Parkinson’s-specific exercise class each week.

Support for carers

Figure 2. The number of people seen for the first time by year.

Figure 3: the numbers attending in 2024 compared with the numbers in 2023, 2022 and 2021.

In 2024, the number of people attending each month consistently exceeded that of previous years, and we anticipate this upward trend in usage will continue in the coming year. As at December 2024, we had 304 active service users, compared to 276 in 2023, 241 in 2022, and 218 in 2021.

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

Awareness : We aim to remain well known in the community in order to make sure that as many people as need our services know about us. The increase in service users reflects our close ties with local community MS and Parkinson’s nurses.

Other publicity to raise awareness included:

Ensuring that our therapies meet the needs of our service users

We have enhanced our surveys by introducing targeted assessments for symptoms of MS and Parkinson’s, alongside our annual survey, enabling a more accurate measurement of our services' impact. Additionally, our clinical team has standardised the quantitative outcomes to ensure consistency.

80% of MS participants reported improvement or no decline in their wellbeing across seven specific questions.

Over 80% of Parkinson’s respondents stated that they were sleeping better, their anxiety and confidence had improved/stayed the same, and that they took a shorter time to do things/maintained the same level.

Our annual survey asked service users how the therapies that we provide have addressed their symptoms. We have used the responses to support decisions on where additional therapies would be beneficial.

The four symptoms that were identified by the most people as needing more support were ‘MS Pain’, ‘Bladder and Bowel Function’, ‘Cognition’ and ‘Balance’. For each of these symptoms we already offer a range of therapies that have been shown to help, so service users are being made aware of these as well as us implementing more support. See chart 4.

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2024

Figure 4: This chart summarises the symptoms that people feel have been helped by the therapies we offer, and where they feel they need more support.

3. Financial viability

Objective:

To develop potential new and existing income streams as part of a robust funding framework to meet our short and long term, funding needs. To continue to manage our services efficiently and proactively, delivering quality services in a cost-effective manner.

Financial Review

We receive no statutory funding and rely entirely on the generosity of our donors and the efforts of our volunteers and staff to sustain and develop the wide range of services and therapies we have been providing for the benefit of people living with MS in Bedfordshire, Northamptonshire and surrounding areas.

Following a successful pilot scheme, we opened our doors to new members who are living with Parkinson’s. This project has been generously supported by funding from the Harpur Trust.

2024 produced a surplus of £61,732, total revenue was £538,306 with costs of £476,574. Member donations rose to £103,304 other donations were £96,504 and charity shop proceeds rose to £46,315. We continue to benefit from funding granted to us by The National Lottery

For 2025, we have budgeted for a deficit of £79,000, based on total income of £526,000. Wage costs are set to increase to £393,000 as we extend the number of therapy hours available and add more staff as we plan for the future.

We are immensely grateful to all our supporters who help us raise income in many ways:

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

Reserves

At the end of the year our reserves were:

The Centre is currently reviewing its property requirements and knows that any improvements may in the first instance be paid for from existing reserves.

This is in line with our reserves policy, a copy of which may be found on our website, of having 6 to 12 months of running costs within free reserves. The average of this for the 2024 FY is approx. £350k and after removing the budgeted deficit there is still sufficient funds available.

We are deeply grateful for the generous support of our donors, some of whom have been supporting us over several years. The £176,195 in trust fund income has been pivotal in advancing our five-year strategy with confidence, strengthening our mental health and wellbeing services, and expanding our support to individuals with Parkinson’s.

In 2024, we were especially thankful to receive generous support from:

Persimmons Community Champions Morrisons Foundation

Hospital Saturday Fund		 Bruce Wake
Potton Consolidated Charity N Smith Charitable Settlement

Gale Family Charity Trust		 Robert Lucas

The Strangward Trust		 St John's Hospital Trust
AKO Foundation Sport England
February Foundation
Amateur Trust
Wixamtree Trust Page Fund
Frank Branston Trust

The National Lottery Community Fund : We are immensely grateful for support from the National Lottery Community Fund for generously part-supporting our services for 5 years commencing in 2024. They have been instrumental in enabling us to continue making a positive impact on the lives of those affected by MS and Parkinson’s.

Harpur Trust: We are also incredibly grateful to the Harpur Trust for recognising our vision of expanding our services to the Parkinson’s community and supporting this initiative with a generous grant to help us get started, following our successful 10-month Parkinson’s pilot trial.

The following funding from Trusts was restricted for specific purposes:

Trusts Amount Restricted to
Hospital SaturdayFund £2,000 FES equipment and training
Potton Consolidated Charity £750 Therapies for service users in SG19postcode
The Strangward Trust £1,000 One Parkinson’s user
FebruaryFoundation £5,000 Oxygen therapy,to be used in 6 months
Wixamtree Trust £10,000 Mental Health and Wellbeingservice
Frank Branston Trust £9,622 Hydrotherapyfor service users from Beds
Morrisons Foundation £6,490 Equipment: multi-gym
Bruce Wake £1,358 Equipment: Pilates chairs and Blazepod trainer
Harpur Trust £31,500 Parkinson’s service users,Bedford
N Smith Charitable Settlement £1,000 Mental Health and Wellbeingservice
Robert Lucas £2,500 Therapies for service users from Shefford
St John’s Hospital Trust £5,000 Mental Health and Wellbeingservice
Sport England £11,790 Exercise sessions for Parkinson’s users only
Amateur Trust £15,000 Cardiovascular exercise sessions

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2024

4. Development of our facilities so that they continue to meet our needs whilst both membership and therapies grow and diversify

Objectives:

To create a facility management plan that can meet our needs for additional space to accommodate the significant growth in numbers of service users and therapies that are forecast by year 5 of our plan.

Our facility development plan will be designed to be viable in terms of capital investment and impact on future running costs. The facility will become a valuable asset to our community.

More progress on this objective will be made in 2025.

5. Increased engagement with our key stakeholders to make them an integral part of the MS Therapy Centre’s future

Objectives:

To ensure that service users are an integral part of our development process, and that their voice is heard when evaluating the organisation’s performance at each step of the way forward.

To include staff members, the local community and the business community in our decision making and service delivery. To build on our success with volunteers by incorporating volunteering opportunities, that give value to both the individual and the MS Therapy Centre, in all aspects of our work.

To continue to develop partnerships with sympathetic organisations so that we can provide a wide range of services and resources as possible.

Achievements:

Our Members’ Forum was set up in 2024 and meets every two months with attendance by service users and carers from both our MS and Parkinson’s communities. The group receives information from the trustee meetings and feeds their ideas into the management team.

“The MS Therapy Centre has been hugely important in providing self-motivation and a d| sense of ownership of the challenges i presented by MS and increasing selfconfidence in facing them.”

“It is good to mix with other service users and staff who understand the condition.”

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

Staff Members:

We are very appreciative of our dedicated and skilled team who are essential to providing an excellent service for our users. During 2024 we employed (based on 1 FTE equal to 37.5 hours ):

1 manager 0.93 FTE
1 part time receptionist 0.61 TFE
2 part time physiotherapists (combined) 0.87 FTE
1 part time physio assistant 0.48 FTE
1 part time therapy assistant 0.45 FTE
1 part time exercise therapist 0.69 FTE
1 part time health and wellbeing coach 0.19 FTE
1 part time trust fundraiser 0.67 FTE
1 part time minibus driver 0.64 FTE
1 part time bookkeeper 0.21 FTE
1 part time cleaner 0.24 FTE
1 part time development coordinator 0.80 FTE
1 part time fundraising and community liaison officer 0.80 FTE

We do not use any external fundraising companies.

We contract sessions with self-employed counsellors and other complementary therapists who provide Massage, Bowen Technique, Reflexology, Pilates and Acupuncture.

Volunteers

Our services are supported by a team of committed volunteers who continue to be one of our greatest assets. We have not only increased regular volunteer numbers to over 70, but also formed specialised teams, such as the ‘Art team,’ ‘Fundraising team,’ and ‘User Support’ team. These initiatives foster teamwork, enhance volunteer satisfaction, and contribute to higher retention rates.

Volunteers run the oxygen therapy service, carry out various regular admin tasks, do gardening, odd jobs, act as Trustees and organise a large number of fundraising activities, from running our charity shops to organising monthly sales and other annual events.

Additional volunteers are heavily involved in representing us at the local Bedford Park Summer Sessions (120+), our Pop-Up Art Exhibition and Sale (60+) and Christmas craft festival.

Increased Community Access to Facilities at the MS Therapy Centre

2024 has seen developments in our strategic partnerships, including a strong collaboration with Parkinson’s UK and a supportive local Trust, that has enabled us to successfully broaden our reach to the Parkinson’s community. In addition:

Risk Management

The MS Therapy Centre is very aware of managing risk in order to provide safe and consistent therapies to our service users. The charity Trustees have given consideration to the major risks to which the charity is exposed and satisfied themselves that systems or procedures are established in order to manage those risks

We carry out continuous monitoring and immediate response to potential risks, in particular in the areas of financial risk, risk to safety of people attending the MS Therapy Centre, and risk to our reputation. All identified risks are logged in our risk register and are reported by the Centre Manager to the Trustees, who ensure that immediate action is taken to implement measures to reduce risk to acceptable levels.

The Trustees meet every six-eight weeks but are also available at all times to assist the manager in assessing all risks and mitigating those risks before they evolve into serious issues.

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

Statement of Trustees' responsibilities

The trustees, who are also the directors of Bedfordshire And Northamptonshire Multiple Sclerosis Therapy Centre Limited for the purpose of company law, are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company Law requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that year.

In preparing these financial statements, the trustees are required to:

The trustees are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The Trustees are responsible for maintenance and integrity of the corporate and financial information included on the charitable company's website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

Each of the persons who is a Trustee at the date of approval of this report confirms that:

The independent examiner is deemed to have been re-appointed in accordance with section 487 of the Companies Act 2006.

Small Company Provisions

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption .

The Trustees' annual report was approved on 5 June 2025 and signed on behalf of the Board of Trustees by:

Melanie Hawman

Charity Secretary

5 June 2025

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

INDEPENDENT EXAMINER'S REPORT

TO THE TRUSTEES OF BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

I report to the trustees on my examination of the financial statements of Bedfordshire And Northamptonshire Multiple Sclerosis Therapy Centre Limited (the charitable company) for the year ended 31 December 2024.

This report is made solely to the charitable company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our work has been undertaken so that we might state to the company's members those matters we are required to state to them in an independent examiner's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our work, for this report, or for the opinions we have formed.

Responsibilities and basis of report

As the trustees of the charitable company (and also its directors for the purposes of company law), you are responsible for the preparation of the financial statements in accordance with the requirements of the Companies Act 2006.

Having satisfied myself that the financial statements of the charitable company are not required to be audited under Part 16 of the Companies Act 2006 and are eligible for independent examination, I report in respect of my examination of the charitable company’s financial statements carried out under section 145 of the Charities Act 2011. In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the Charities Act 2011.

Independent examiner's statement

Since the charitable company’s gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of the ICAEW, which is one of the listed bodies.

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached.

Caroline Brazier ACA DChA

Cansdales Business Advisers Limited St Mary’s Court The Broadway Old Amersham Bucks HP70UT

Dated: 6 June 2025

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT

FOR THE YEAR ENDED 31 DECEMBER 2024

Unrestricted
Designated
Restricted
funds
funds
funds
2024
2024
2024
Notes
£
£
£
Income and endowments from:
Donations and legacies
3
209,463
-
85,789
Charitable activities
6
140,984
-
-
Other trading activities
4
63,931
-
-
Investments
5
23,212
-
-
Other income
7
8,246
-
-
Total income
445,836
-
85,789
Expenditure on:
Raising funds
8
86,325
-
-
Charitable activities
9
365,177
-
25,073
Total expenditure
451,502
-
25,073
Net gains/(losses) on investments
6,682
-
-
Net income
1,016
-
60,716
Transfers between funds
(522,638)
600,000
(77,362)
Net movement in funds
12
(521,622)
600,000
(16,646)
Reconciliation of funds:
Fund balances at 1 January 2024
734,956
-
121,147
Fund balances at 31 December 2024
213,334
600,000
104,501		 Total
Unrestricted
Restricted
funds
funds
2024
2023
2023
£
£
£
295,252
169,997
136,814
140,984
127,798
-
63,931
46,582
-
23,212
9,157
-
8,246
22,871
-
531,625
376,405
136,814
86,325
46,702
-
390,250
320,978
16,650
476,575
367,680
16,650
6,682
8,042
-
61,732
16,767
120,164
-
77,328
(77,328)
61,732
94,095
42,836
856,103
640,861
78,311
917,835
734,956
121,147		 Total
2023
£
306,811
127,798
46,582
9,157
22,871
513,219
46,702
337,628
384,330
8,042
136,931
-
136,931
719,172
856,103

The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

BALANCE SHEET

AS AT 31 DECEMBER 2024

2024 2023
Notes £ £ £ £
Fixed assets
Tangible assets 14 122,243 143,319
Investments 15 235,889 222,521
358,132 365,840
Current assets
Debtors 16 18,314 16,941
Cash at bank and in hand 565,314 496,061
583,628 513,002
Creditors: amounts falling due within one year 17 (23,925) (22,739)
Net current assets 559,703 490,263
Total assets less current liabilities 917,835 856,103
Net assets 917,835 856,103
The funds of the charitable company
Designated funds 19 600,000 -
Restricted income funds 21 104,501 121,147
Unrestricted funds 213,334 734,956
917,835 856,103

The company is entitled to the exemption from the audit requirement contained in section 477 of the Companies Act 2006, for the year ended 31 December 2024.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the trustees on 5 June 2025

Kay Taylor (Chair) Trustee 5 June 2025

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 DECEMBER 2024

Notes
Cash flows from operating activities
Cash generated from operations
24
Investing activities
Purchase of tangible fixed assets
Purchase of investments
Proceeds from disposal of investments
Investment income received
Net cash generated from/(used in) investing activities
Net cash generated from financing activities
Net increase in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year		 2024
£
(8,426)
(53,581)
46,894
23,212		 £
61,154
8,099
-
69,253
496,061
565,314		 2023
£
(56,401)
(5,215)
1,545
9,157		 £
142,556
(50,914)
-
91,642
404,419
496,061

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024

1 Accounting policies

Bedfordshire And Northamptonshire Multiple Sclerosis Therapy Centre Limited is a private company limited by guarantee incorporated in England and Wales. The registered office is Bradbury House, 155 Barkers Lane, Bedford, MK41 9RX.

1.1 Accounting convention

The financial statements have been prepared in accordance with the charitable company's Memorandum and Articles of Association, the Companies Act 2006, FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (effective 1 January 2019). The charitable company is a Public Benefit Entity as defined by FRS 102.

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through income or expenditure.

The financial statements are prepared in sterling, which is the functional currency of the entity.

1.2 Going concern

There are no material uncertainties about the charity's ability to continue.

Disclosure exemptions

The entity satisfies the criteria of being a qualifying entity as defined in FRS 102. As such, advantage has been taken of the following disclosure exemptions available under paragraph 1.12 of FRS 102:

1.3 Charitable funds

Unrestricted funds are available for use at the discretion of the trustees to further any of the charity's purposes

Designated funds are unrestricted funds earmarked by the trustees for particular future project or commitment.

Restricted funds are subjected to restrictions on their expenditure declared by the donor or through the terms of an appeal, and fall into one of two sub-dasses: restricted income funds or endowment funds.

1.4 Income

All incoming resources are included in the statement of financial activities when entitlement has passed to the charity; it is probable that the economic benefits associated with the transaction will flow to the charity and the amount can be reliably measured. The following specific policies are applied to particular categories of income

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

1 Accounting policies

(Continued)

1.5 Expenditure

Expenditure is recognised on an accruals basis as a liability is incurred. Expenditure includes any VAT which cannot be fully recovered, and is classified under headings of the statement of financial activities to which it relates:

All costs are allocated to expenditure categories reflecting the use of the resource. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs are apportioned between the activities they contribute to on a reasonable, justifiable and consistent basis.

1.6 Tangible fixed assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other recognised gains and losses, unless it reverses a charge for impairment that has previously been recognised as expenditure within the statement of financial activities. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other recognised gains and losses, except to which it offsets any previous revaluation gain, in which case the loss is shown within other recognised gains and losses on the statement of financial activities.

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Leasehold improvements 20% reducing balance Fixtures and fittings 20% reducing balance Hydro pool 20% reducing balance Minibus 20% reducing balance

1.7 Fixed asset investments

Unlisted equity investments are initially recorded at cost, and subsequently measured at fair value. If fair value cannot be reliably measured, assets are measured at cost less impairment.

Listed investments are measured at fair value with changes in fair value being recognised in income or expenditure.

1.8 Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets.

For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the charity are assigned to those units.

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

1 Accounting policies

(Continued)

1.9 Stocks

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.

1.10 Cash and cash equivalents

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.

1.11 Financial instruments

A financial asset or a financial liability is recognised only when the charity becomes a party to the contractual provisions of the instrument.

Basic financial instruments are initially recognised at the amount receivable or payable including any related transaction costs.

Current assets and current liabilities are subsequently measured at the cash or other consideration expected to be paid or received and not discounted.

Debt instruments are subsequently measured at amortised cost.

Where investments in shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in income and expenditure. All other such investments are subsequently measured at cost less impairment.

Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Other financial instrurnents are subsequently measured at fair value, with any changes recognised in the statement of financial activities, with the exception of hedging instruments in a designated hedging relationship.

Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised under the appropriate heading in the statement of financial activities in which the initial gain was recognised.

For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics.

Any reversals of impairment are recognised immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

Defined contribution plans

Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund.

When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as an expense in the period in which it arises.

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

1 Accounting policies

(Continued)

1.12 Government grants

Government grants are recognised at the fair value of the asset received or receivable. Grants are not recognised until there is reasonable assurance that the charity will comply with the conditions attaching to them and the grants will be received.

Where the grant does not impose specified future performance-related conditions on the recipient, it is recognised in income when the grant proceeds are received or receivable. Where the grant does impose specified future performance-related conditions on the recipient, it is recognised in income only when the performance-related conditions have been met. Where grants received are prior to satisfying the revenue recognition criteria, they are recognised as a liability.

1.13 Limited by guarantee

The organisation is a charitable company limited by guarantee, incorporated in 1988 and is governed by memorandum and articles of association as renewed and dated 9th January 2008.

2 Judgements and key sources of estimation uncertainity

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

3 Income from donations and legacies

Unrestricted
Restricted
funds
funds
2024
2024
£
£
Donations and gifts
207,582
85,789
Sundry Grants
1,881
-
209,463
85,789		 Total
Unrestricted
Restricted
funds
funds
2024
2023
2023
£
£
£
293,371
168,496
136,814
1,881
1,501
-
295,252
169,997
136,814		 Total
2023
£
305,310
1,501
306,811

4 Income from other trading activities

Unrestricted Unrestricted
funds funds
2024 2023
£ £
Art event 17,615 19,475
Charity shop 46,316 27,107
63,931 46,582

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

5 Income from investments
Unrestricted Unrestricted
funds funds
2024 2023
£ £
Income from listed investments 7,774 6,831
Interest receivable 15,438 2,326
23,212 9,157
6 Income from charitable activities
Unrestricted Unrestricted
funds funds
2024 2023
£ £
Charitable activities
Fundraising events 37,680 27,650
40th including Ruby - 15,415
Members donations 103,304 84,733
140,984 127,798
7 Other income
Unrestricted Unrestricted
funds funds
2024 2023
£ £
Other income 8,246 22,871
8,246 22,871

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

8 Expenditure on raising funds

Unrestricted
funds
2024
£
Fundraising and publicity
Staff costs
65,080
Light & heat
-
Insurance
2,594
Legal and professional fees
820
Miscellaneous cost
4,587
Depreciation and impairment
2,428
Independent examination fee
-
Investment management
268
Share of support costs (see note 10)
9,605
Share of governance costs (see note 10)
943
86,325		 Total
Unrestricted
funds
2024
2023
£
£
65,080
42,573
-
(1,470)
2,594
971
820
-
4,587
-
2,428
-
-
(1,068)
268
620
9,605
1,470
943
1,068
86,325
46,702		 Total
2023
£
42,573
(1,470)
971
-
-
-
(1,068)
620
1,470
1,068
46,702

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

9 Expenditure on charitable activities

Therapies
Fundraising
and publicity
2024
2024
£
£
Staff costs
147,445
51,933
Depreciation and
impairment
25,138
1,937
Oxygen Treatment and
Day care cost
23,347
-
Therapists
61,270
-
40th including Ruby
-
-
Insurance
5,877
2,070
Motor vehicle expenses
5,776
-
Legal and professional
2,466
868
Miscellaneous cost
10,390
19,417
281,709
76,225
Share of support costs
(see note 10)
21,762
7,665
Share of governance
costs (see note 10)
2,136
753
305,607
84,643
Analysis by fund
Unrestricted funds
280,534
84,643
Restricted funds
25,073
-
305,607
84,643		 Total
Therapies
Fundraising
and publicity
2024
2023
2023
£
£
£
199,378
161,206
-
27,075
22,193
-
23,347
27,678
-
61,270
36,481
-
-
-
4,296
7,947
7,069
1,000
5,776
6,702
-
3,334
12,992
200
29,807
3,902
11,369
357,934
278,223
16,865
29,427
39,514
-
2,889
2,826
200
390,250
320,563
17,065
365,177
303,913
17,065
25,073
16,650
-
390,250
320,563
17,065		 Total
2023
£
161,206
22,193
27,678
36,481
4,296
8,069
6,702
13,192
15,271
295,088
39,514
3,026
337,628
320,978
16,650
337,628

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

10 Support and Governance cost

Support cost
Fundraising
Therapies Fundraising and
publicity
2024
2024
2024
£
£
£
Light and heat
3,211
7,276
2,562
Printing and stationery
134
302
107
Telephone and postage
466
1,057
372
Repair and maintenance
4,177
9,464
3,334
Rates and water
1,522
3,447
1,214
Bank charges
95
216
76
9,605
21,762
7,665
Governance costs
Independent examiner fees
943
2,136
753
10,548
23,898
8,418		 Total
2024
£
13,049
543
1,895
16,975
6,183
387
39,032
3,832
42,864		 Total
2023
£
13,138
424
2,639
17,794
6,597
392
40,984
4,094
45,078

11 Trustees

None of the trustees (or any persons connected with them) received any remuneration or benefits from the charitable company during the year.

12 Net (expenditure/ (income)
Net (expenditure/ (income) 2024 2023
£ £
The net movement in funds is stated after charging/(crediting):
Fees payable for the independent examination of the charity's financial statements 3,832 7,708
Depreciation of tangible fixed assets 29,503 22,193

13 Employees

The average monthly number of employees during the year was:

The average monthly number of employees during the year was:
2024 2023
Number Number
Number of Therapists, Clinical and Care staff 6 6
Number of Fundraisers 2 2
Number of Administrative Staff 2 2
Number of Management Staff 2 2
Number of Other Staff- Cleaner (1), Minibus Driver (1) 2 2
Total 14 14

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

13
Employees
Employment costs
Wages and salaries
Social security costs
Other pension costs		 (Continued)
2024
2023
£
£
247,953
192,915
12,519
7,346
3,986
3,518
264,458
203,779		 (Continued)
2024
2023
£
£
247,953
192,915
12,519
7,346
3,986
3,518
264,458
203,779
203,779

There were no employees whose annual remuneration was more than £60,000.

14 Tangible fixed assets

Leasehold
improvements
Fixtures and
fittings
Hydro pool
£
£
£
Cost
At 1 January 2024
174,193
201,283
109,093
Additions
-
8,426
-
At 31 December 2024
174,193
209,709
109,093
Depreciation and impairment
At 1 January 2024
171,625
174,702
10,910
Depreciation charged in the year
511
6,157
19,637
At 31 December 2024
172,136
180,859
30,547
Carrying amount
At 31 December 2024
2,057
28,850
78,546
At 31 December 2023
2,568
26,580
98,183		 Minibus
£
41,086
-
41,086
25,098
3,198
28,296
12,790
15,988		 Total
£
525,655
8,426
534,081
382,335
29,503
411,838
122,243
143,319

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

15 Fixed asset investments

Overseas Index
linked securities
Other UK
Investments
Cash or Cash
equivalents
£
£
£
Cost or valuation
At 1 January 2024
194,394
9,983
18,144
Additions
53,659
-
43,196
Revaluations
6,594
90
(2)
Disposals
(35,501)
-
(54,668)
At 31 December 2024
219,146
10,073
6,670
Carrying amount
At 31 December 2024
219,146
10,073
6,670
At 31 December 2023
194,394
9,983
18,144		 Total
£
222,521
96,855
6,682
(90,169)
235,889
235,889
222,521

All investments shown above are held at valuation

Listed Investments

The aggregate market value of listed investments is £229,219 (2023: £204,377)

Financial assets held at fair value

Investments less cash were originally acquired at a cost value of £196,793 (2023: £178,187). The market value of the investments at the year end, amounted to £229,219 (2023: £204,377)

16 Debtors

Debtors
Amounts falling due within one year:
Trade debtors
Prepayments and accrued income		 2024
£
948
17,366
18,314		 2023
£
965
15,976
16,941

17 Creditors: amounts falling due within one year

Trade creditors
Other creditors
Accruals and deferred income		 2024
£
11,462
847
11,616
23,925		 2023
£
3,151
726
18,862
22,739

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

18 Pension and other post retirement benefit schemes
2024 2023
Defined contribution schemes £ £
Charge to profit or loss in respect of defined contribution schemes 3,986 3,518

19 Designated funds -

These are Designated funds funds which are material to the charitable company's activities.

At 1
Escape ramp upper floor
Replacement of mini bus
Property/lease renewal
Refurbishment fund		 January
2024
Transfers At 31 December
2024
£
£
£
-
170,000
170,000
-
70,000
70,000
-
260,000
260,000
-
100,000
100,000
-
600,000
600,000		 January
2024
Transfers At 31 December
2024
£
£
£
-
170,000
170,000
-
70,000
70,000
-
260,000
260,000
-
100,000
100,000
-
600,000
600,000
600,000

20 Unrestricted funds

The unrestricted funds of the charity comprise the unexpended balances of donations and grants which are not subject to specific conditions by donors and grantors as to how they may be used. These include designated funds which have been set aside out of unrestricted funds by the trustees for specific purposes.

At 1
Refurbishment fund
General funds
Previous year:
At 1
Refurbishment fund
General funds		 January
2024
Incoming
resources
Resources
expended
Transfers Gains and losses At 31 December
2024
£
£
£
£
£
£
100,000
-
-
(100,000)
-
-
634,956
445,836
(451,502)
(422,638)
6,682
213,334
734,956
445,836
(451,502)
(522,638)
6,682
213,334
January
2023
Incoming
resources
Resources
expended
Transfers Gains and losses At 31 December
2023
£
£
£
£
£
£
100,000
-
-
-
-
100,000
540,861
376,405
(367,680)
77,328
8,042
634,956
640,861
376,405
(367,680)
77,328
8,042
734,956		 January
2024
Incoming
resources
Resources
expended
Transfers Gains and losses At 31 December
2024
£
£
£
£
£
£
100,000
-
-
(100,000)
-
-
634,956
445,836
(451,502)
(422,638)
6,682
213,334
734,956
445,836
(451,502)
(522,638)
6,682
213,334
January
2023
Incoming
resources
Resources
expended
Transfers Gains and losses At 31 December
2023
£
£
£
£
£
£
100,000
-
-
-
-
100,000
540,861
376,405
(367,680)
77,328
8,042
634,956
640,861
376,405
(367,680)
77,328
8,042
734,956
734,956

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

21 Restricted funds

The restricted funds of the charity comprise the unexpended balances of donations and grants held on trust subject to specific conditions by donors as to how they may be used.

At 1
Restricted funds
Previous year:
At 1
Restricted funds
Analysis of net assets between funds
At 31 December 2024:
Tangible assets
Investments
Current assets/(liabilities)
At 31 December 2023:
Tangible assets
Investments
Current assets/(liabilities)		 January
2024
Incoming
resources
Resources
expended
Transfers At 31 December
2024
£
£
£
£
£
121,147
85,789
(25,073)
(77,362)
104,501
January
2023
Incoming
resources
Resources
expended
Transfers At 31 December
2023
£
£
£
£
£
78,311
136,814
(16,650)
(77,328)
121,147
Unrestricted
Designated
Restricted
Total
funds
funds
funds
2024
2024
2024
2024
£
£
£
£
17,742
-
104,501
122,243
-
235,889
-
235,889
195,592
364,111
-
559,703
213,334
600,000
104,501
917,835
Unrestricted
Designated
Restricted
Total
funds
funds
funds
2023
2023
2023
2023
£
£
£
£
22,172
-
121,147
143,319
222,521
-
-
222,521
490,263
-
-
490,263
734,956
-
121,147
856,103		 January
2024
Incoming
resources
Resources
expended
Transfers At 31 December
2024
£
£
£
£
£
121,147
85,789
(25,073)
(77,362)
104,501
January
2023
Incoming
resources
Resources
expended
Transfers At 31 December
2023
£
£
£
£
£
78,311
136,814
(16,650)
(77,328)
121,147
Unrestricted
Designated
Restricted
Total
funds
funds
funds
2024
2024
2024
2024
£
£
£
£
17,742
-
104,501
122,243
-
235,889
-
235,889
195,592
364,111
-
559,703
213,334
600,000
104,501
917,835
Unrestricted
Designated
Restricted
Total
funds
funds
funds
2023
2023
2023
2023
£
£
£
£
22,172
-
121,147
143,319
222,521
-
-
222,521
490,263
-
-
490,263
734,956
-
121,147
856,103
Total
2024
£
122,243
235,889
559,703
917,835
Total
2023
£
143,319
222,521
490,263
856,103

22 Analysis of net assets between funds

23 Related party transactions

There were no disclosable related party transactions during the year (2023 - none).

BEDFORDSHIRE AND NORTHAMPTONSHIRE MULTIPLE SCLEROSIS THERAPY CENTRE LIMITED

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024

24
Cash generated from operations
Surplus for the year
Adjustments for:
Investment income recognised in statement of financial activities
Gain on disposal of investments
Fair value gains and losses on investments
Depreciation and impairment of tangible fixed assets
Movements in working capital:
(Increase) in debtors
Increase in creditors
Cash generated from operations		 2024
£
61,732
(23,212)
(5,666)
(1,016)
29,503
(1,373)
1,186
61,154		 2023
£
136,931
(9,157)
(8,042)
-
22,193
(10,413)
11,044
142,556